We've found
					11,964 Cardiology				
					clinical trials				
				
			
		
							
  	
	Heart Failure Clinical Trial
	Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Other Clinical Trial
	Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	The CAROLE (CArdiac Related Oncologic Late Effects) Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	The CAROLE (CArdiac Related Oncologic Late Effects) Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 3/29/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Aortic Valve Stenosis Clinical Trial
	Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
		Status: Enrolling
  
							
  	
	Aortic Valve Stenosis Clinical Trial
	Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Aortic Valve Stenosis Clinical Trial
	Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
		Status: Enrolling
  
							
  	
	Aortic Valve Stenosis Clinical Trial
	Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Physiologic Assessment of Coronary Stenosis Following PCI
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Physiologic Assessment of Coronary Stenosis Following PCI
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Click here to add this to my saved trials
  
							
  
  
  
  
			Click here to add this to my saved trials
	    
	 Click here to add this to my saved trials
  
							
  
  
  
  
			Click here to add this to my saved trials
	    
	 Click here to add this to my saved trials
  
							
  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Failure Aggravated Clinical Trial
	Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients With Worsening Heart Failure
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Cardiac Failure Aggravated Clinical Trial
	Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients With Worsening Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Failure Aggravated Clinical Trial
	Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients With Worsening Heart Failure
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Cardiac Failure Aggravated Clinical Trial
	Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients With Worsening Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Failure Aggravated Clinical Trial
	Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients With Worsening Heart Failure
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Cardiac Failure Aggravated Clinical Trial
	Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients With Worsening Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure; With Decompensation Clinical Trial
	Heart Sounds Registry
		Status: Enrolling,
							Phase
  
							
  	
	Heart Failure; With Decompensation Clinical Trial
	Heart Sounds Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure; With Decompensation Clinical Trial
	Heart Sounds Registry
		Status: Enrolling,
							Phase
  
							
  	
	Heart Failure; With Decompensation Clinical Trial
	Heart Sounds Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Heart Failure Clinical Trial
	EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/23/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Venous Leg Ulcer Clinical Trial
	Dose-response Relationship Study of S42909 on Leg Ulcer Healing
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Venous Leg Ulcer Clinical Trial
	Dose-response Relationship Study of S42909 on Leg Ulcer Healing
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Critical Limb Ischemia Clinical Trial
	Pilot Study to Investigate Safety, Effectiveness and Feasibility of LimFlow Stent Graft System
		Status: Enrolling
  
							
  	
	Critical Limb Ischemia Clinical Trial
	Pilot Study to Investigate Safety, Effectiveness and Feasibility of LimFlow Stent Graft System
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology, Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
	Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology, Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
	Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology, Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
	Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology, Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
	Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Arrest Clinical Trial
	RHAPSody: Diagnostic Utility of RUSH Following ROSC
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Arrest Clinical Trial
	RHAPSody: Diagnostic Utility of RUSH Following ROSC
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Left Ventricular Dysfunction Clinical Trial
	Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling
  
							
  	
	Left Ventricular Dysfunction Clinical Trial
	Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Intracranial Aneurysm Clinical Trial
	Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device
		Status: Enrolling
  
							
  	
	Intracranial Aneurysm Clinical Trial
	Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Intracranial Aneurysm Clinical Trial
	Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device
		Status: Enrolling
  
							
  	
	Intracranial Aneurysm Clinical Trial
	Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Sudden Cardiac Death Clinical Trial
	The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest
		Status: Enrolling,
							Phase
  
							
  	
	Sudden Cardiac Death Clinical Trial
	The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Post-Infarction Ventricular Septal Defect Clinical Trial
	The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Post-Infarction Ventricular Septal Defect Clinical Trial
	The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/1/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
		Status: Enrolling
  
							
  	
	Coronary Artery Disease Clinical Trial
	The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Paroxysmal Supraventricular Tachycardia Clinical Trial
	Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Paroxysmal Supraventricular Tachycardia Clinical Trial
	Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Paroxysmal Supraventricular Tachycardia Clinical Trial
	Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Paroxysmal Supraventricular Tachycardia Clinical Trial
	Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Paroxysmal Supraventricular Tachycardia Clinical Trial
	Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Paroxysmal Supraventricular Tachycardia Clinical Trial
	Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 
  
						
				
			
We've found
					11,964 Cardiology
				
					clinical trials
				
				
				
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 3/29/2018
  
  
  The CAROLE (CArdiac Related Oncologic Late Effects) Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 3/29/2018
Click here to add this to my saved trials
	    
	 
  	
	Aortic Valve Stenosis Clinical Trial
	
Updated: 12/31/1969
  
  
  Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Aortic Valve Stenosis Clinical Trial
	
Updated: 12/31/1969
  
  
  Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Physiologic Assessment of Coronary Stenosis Following PCI
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  Click here to add this to my saved trials
	    
	 
  Click here to add this to my saved trials
	    
	 
  Click here to add this to my saved trials
	    
	 
  	
	Cardiac Failure Aggravated Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients With Worsening Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Failure Aggravated Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients With Worsening Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Failure Aggravated Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients With Worsening Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure; With Decompensation Clinical Trial
	
Updated: 12/31/1969
  
  
  Heart Sounds Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure; With Decompensation Clinical Trial
	
Updated: 12/31/1969
  
  
  Heart Sounds Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 4/23/2018
  
  
  EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 4/23/2018
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Venous Leg Ulcer Clinical Trial
	
Updated: 12/31/1969
  
  
  Dose-response Relationship Study of S42909 on Leg Ulcer Healing
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Critical Limb Ischemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Pilot Study to Investigate Safety, Effectiveness and Feasibility of LimFlow Stent Graft System
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology, Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
	
Updated: 12/31/1969
  
  
  Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology, Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
	
Updated: 12/31/1969
  
  
  Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Arrest Clinical Trial
	
Updated: 12/31/1969
  
  
  RHAPSody: Diagnostic Utility of RUSH Following ROSC
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Left Ventricular Dysfunction Clinical Trial
	
Updated: 12/31/1969
  
  
  Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Intracranial Aneurysm Clinical Trial
	
Updated: 12/31/1969
  
  
  Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Intracranial Aneurysm Clinical Trial
	
Updated: 12/31/1969
  
  
  Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Sudden Cardiac Death Clinical Trial
	
Updated: 12/31/1969
  
  
  The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Post-Infarction Ventricular Septal Defect Clinical Trial
	
Updated: 5/1/2018
  
  
  The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/1/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Paroxysmal Supraventricular Tachycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Paroxysmal Supraventricular Tachycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Paroxysmal Supraventricular Tachycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	